AzTrials
AzTrials

Respiratory DistressALTIPICUNCT05328206

Air Leak Test In Pediatric Intensive Care Unit

An observational study of Respiratory Distress and Upper Airway Obstruction, run by Assistance Publique - Hôpitaux de Paris at 19 sites in France.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Respiratory distress by upper airway obstruction (UAO) is the primary etiology of extubation failure in children hospitalized in pediatric intensive care unit (PICU). This complication may require various invasive therapeutic which increase morbi-mortality and length of hospital stay. Read more about this study

Who is it for?
Ages 2 days to 17 years
How many people
900 participants
Where
19 sitesFrance
Study dates
5 Oct 2022to 3 Apr 2024
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 2 days to 17 years
  • All sexes
  • No healthy volunteers
  • Child

Study population: Child aged 2 days post-term to 18 years intubated with a cuffed endotracheal tube (c-ETT)

Who may be able to join

  • ≥ 2 day to < 18 years of age,
  • Ventilated through a cuffed endotracheal tube,
  • Expected duration of mechanical ventilation ≥ 24 hours,
  • Having a cuff leak test prior extubation,
  • Placed on the assist control setting during CLT,
  • No opposition from parents or patient

Who cannot join

  • Receiving mechanical ventilation via a tracheostomy,
  • Unplanned extubation,
  • Patient with long-term non-invasive ventilation (NIV),
  • History of upper airways pathology,
  • Surgery of upper airways less than 1 month old,
  • Limitations of medical care in place,
Show all 9Show fewer
  • Parents or patient opposition,
  • Already been included in this study,
  • Not affiliated with social security.

Trial locations and contacts

19 sites in 1 country.

Boris Lacarra, Dr contact

+33140032187

boris.lacarra@aphp.fr

Matthieu Resche-Rigon, Pr contact

+33142499742

matthieu.resche-rigon@u-paris.fr

19 sites in 1 country

France19 sites, 19 recruiting
  • CHU Bordeaux Pellegrin

    Bordeaux

    Olivier Brissaud

    Recruiting
  • Hôpital Haut-Lévêques, maladies cardio-vasculaires congénitales

    Bordeaux

    Julien Gotchac

    Recruiting
  • Hôpital Haut-Lévêques, réanimation chirurgicale cardiopédiatrique

    Bordeaux

    Elise Langouet

    Recruiting
  • CHU Côte de Nacre

    Caen

    David Brossier

    Recruiting
  • CHU Estaing

    Clermont-Ferrand

    Nadia Savy

    Recruiting
  • Hôpital Raymond Poincaré

    Garches

    Justine Zini

    Recruiting
  • CHU Grenoble Alpes

    Grenoble

    Guillaume Mortamet

    Recruiting
  • CHU Bicêtre

    Le Kremlin-Bicêtre

    Pierre Tissière

    Recruiting
  • CHU Jeanne de Flandres

    Lille

    Stéphane Leteurtre

    Recruiting
  • Hôpital Femme Mère Enfant HCL

    Lyon

    Robin Pouyau

    Recruiting
  • CHU de La Timone - AP-HM

    Marseille

    Fabrice Michel

    Recruiting
  • CHU Nancy

    Nancy

    Arnaud Wiedemann

    Recruiting
  • CH Marie Lannelongue

    Paris

    Angèle Boët

    Recruiting
  • Debré, AP-HP Nord

    Paris

    Boris Lacarra

    Recruiting
  • Necker, AP-HP Centre - Anesthésie

    Paris

    Juliette Montmayeur

    Recruiting
  • Necker, AP-HP Centre - Médecine intensive

    Paris

    Sylvain Renolleau

    Recruiting
  • Trousseau, AP-HP Est

    Paris

    Jérôme Rambaud

    Recruiting
  • CHU Toulouse

    Toulouse

    Marie-Odile Marcoux

    Recruiting
  • CHU Clocheville

    Tours

    Julie Chantreuil

    Recruiting

Other trials in France

About this study

Official title: Air Leak Test in Pediatric Intensive Care Unit : a Multicentric and Prospective Study

Respiratory distress by upper airway obstruction (UAO) is the primary etiology of extubation failure in children hospitalized in pediatric intensive care unit (PICU).

This complication may require various invasive therapeutic which increase morbi-mortality and length of hospital stay.

Read more

Cuff leak test (CLT) measured prior extubation to predict post-extubation UAO has been widely used in adult. The test compared expired tidal volume with cuff inflated and cuff deflated in order to predict UAO.

Despite its frequent use in PICU, his predictive value to predict UAO in children is still poorly documented.

Therefore, we conducted the first multicentric, prospective study to evaluate the CLT as a predictor of post-extubation UAO in critically ill children.

The Primary objective is to assess the effectiveness of CLT in predicting severe respiratory distress by UAO within 48 hours of extubation in a critically ill children.

Being tested
Standard of care for intubated children
Medical subject headings
Dyspnea, Airway Obstruction

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Standard of care for intubated childrenOther

    Patient ventilated through a cuffed endotracheal tube and having a cuff leak test prior extubation

Study groups in NCT05328206
Study groupRoleWhat they receive
Standard of care for intubated children with a cuffed endotracheal tube (c-ETT)Not described
Receives: Other: Standard of care for intubated children

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Respiratory distress by post-extubation upper airway obstruction (UAO)

    The respiratory distress will be assessed using the Westley score. The Westley score evaluates the severity of respiratory function by assessing five factors: level of consciousness, cyanosis, stridor, air entry, and retractions. A specific point values are given for each factor, and the final score sum has a range from 0 to 17. The greater the respiratory distress the more imminent the respiratory distress. Respiratory distress will be defined by a Westley score greater than or equal to 4 with a minimum of 1 for the "stridor" item, at the initiation of at least one of the following treatments (IVC, LNHD, NIV (CPAP, BiPAP or any other mode with two pressure levels), MV(reintubation or tracheotomy)).

    Measured: within 48 hours

Secondary outcomes (5)
  1. Cumulative incidence of return to mechanical ventilation (after re-intubation)

    Measured: within 48 hours

  2. Risk factors of severe respiratory distress (RD)

    The respiratory distress will be assessed using the Westley score. The Westley score evaluates the severity of respiratory function by assessing five factors: level of consciousness, cyanosis, stridor, air entry, and retractions. A specific point values are given for each factor, and the final score sum has a range from 0 to 17. The greater the respiratory distress the more imminent the respiratory distress. Respiratory distress will be defined by a Westley score greater than or equal to 4 with a minimum of 1 for the "stridor" item, at the initiation of at least one of the following treatments (IVC, LNHD, NIV (CPAP, BiPAP or any other mode with two pressure levels), MV(reintubation or tracheotomy)).

    Measured: within 48 hours

  3. Proportion of patients with intravenous corticosteroid therapy (IVC)

    Proportion of patients with intravenous corticosteroid therapy (IVC) in progress 12 hours prior to scheduled extubation, whether initiated for extubation or pre-extubation,

    Measured: at inclusion

  4. Predictive score for severe respiratory distress (RD)

    The respiratory distress will be assessed using the Westley score. The Westley score evaluates the severity of respiratory function by assessing five factors: level of consciousness, cyanosis, stridor, air entry, and retractions. A specific point values are given for each factor, and the final score sum has a range from 0 to 17. The greater the respiratory distress the more imminent the respiratory distress. Respiratory distress will be defined by a Westley score greater than or equal to 4 with a minimum of 1 for the "stridor" item, at the initiation of at least one of the following treatments (IVC, LNHD, NIV (CPAP, BiPAP or any other mode with two pressure levels), MV(reintubation or tracheotomy)).

    Measured: within 48 hours

  5. Median length of stay in paediatric intensive care

    Measured: Up to 28 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Apr 2022
  2. Study start5 Oct 2022
  3. Primary completion7 Mar 2024 (estimated)
  4. Study completion3 Apr 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
900 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05328206
Sponsor's protocol ID
APHP220207
Acronym
ALTIPICU
Status last verified
May 2023
First submitted
4 Mar 2022
Last updated
11 May 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Publications

  • Lacarra B, Hayotte A, Naudin J, Maroni A, Geslain G, Poncelet G, Levy M, Resche-Rigon M, Dauger S. Air leak test in the Paediatric Intensive Care Unit (ALTIPICU): rationale and protocol for a prospective multicentre observational study. BMJ Open. 2024 Apr 30;14(4):e081314. doi: 10.1136/bmjopen-2023-081314.

    PubMed 38688666

Questions about this trial

What is this clinical trial studying?

An observational study of Respiratory Distress and Upper Airway Obstruction, run by Assistance Publique - Hôpitaux de Paris at 19 sites in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 11 May 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 19 sites in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Boris Lacarra, Dr (+33140032187, boris.lacarra@aphp.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Respiratory distress by post-extubation upper airway obstruction (UAO) (time frame: within 48 hours). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05328206, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 May 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in